OGN

Handel nachbörslich: 13.31

Organon Co (OGN)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Dividendenhistorie

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Organon Co Stock (OGN) Company Profile

Healthcare (1106)

551-430-6000

30 HUDSON STREET, JERSEY CITY

Nächster Verdiensttermin

Neueste SEC-Einreichungen

OGN's Discussions on Twitter

Compare OGN vs LLY, JNJ, ABBV, AZN, NVS

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
OGN Organon Co	13.31	3.50B	6.16B	246.00M	708.00M	0.9387
LLY Lilly Eli Co	989.87	862.31B	72.25B	25.28B	10.37B	27.78
JNJ Johnson Johnson	224.26	533.03B	96.36B	21.04B	17.80B	8.6488
ABBV Abbvie Inc	207.86	358.27B	62.82B	3.60B	19.98B	2.0274
AZN Astrazeneca Plc	184.54	282.04B	60.48B	10.40B	8.05B	3.3297
NVS Novartis Ag Adr	148.16	277.11B	54.66B	13.58B	16.05B	7.0171

Organon Co Stock (OGN) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-12-09	Eingeleitet	Barclays	Underweight
2025-10-27	Herabstufung	Piper Sandler	Overweight → Underweight
2025-05-02	Herabstufung	Evercore ISI	Outperform → In-line
2024-09-06	Herabstufung	JP Morgan	Neutral → Underweight
2023-11-03	Herabstufung	Goldman	Buy → Neutral
2023-09-21	Eingeleitet	Barclays	Overweight
2023-03-16	Eingeleitet	Raymond James	Outperform
2022-10-14	Herabstufung	BofA Securities	Neutral → Underperform
2022-09-06	Hochstufung	Piper Sandler	Neutral → Overweight
2022-08-05	Herabstufung	BofA Securities	Buy → Neutral
2022-04-27	Eingeleitet	Goldman	Buy
2022-04-06	Fortgesetzt	Morgan Stanley	Equal-Weight
2021-10-07	Eingeleitet	Piper Sandler	Neutral
2021-09-01	Eingeleitet	BofA Securities	Buy
2021-07-22	Eingeleitet	Citigroup	Buy
2021-06-15	Eingeleitet	JP Morgan	Neutral
2021-06-11	Eingeleitet	Morgan Stanley	Equal-Weight
2021-06-10	Eingeleitet	Evercore ISI	Outperform

Alle ansehen

Organon Co Aktie (OGN) Neueste Nachrichten

Finanzdaten der Organon Co-Aktie (OGN)

Organon Co (OGN)

Organon Co Stock (OGN) Company Profile

Compare OGN vs LLY, JNJ, ABBV, AZN, NVS

Organon Co Stock (OGN) Upgrades & Downgrades

Organon Co Aktie (OGN) Neueste Nachrichten

Organon & Co is the best performing healthcare stock in April - MSN

Notable healthcare headlines for the week: J&J, Abbott and Organon in focus - MSN

Sun Pharma shares jump after Organon acquisition deal; top gainer on Nifty 50 - MSN

Mega Sun Pharma-Organon Deal | Organon A Strategic Fit For Sun Pharma, Says Macquarie Capital (Wch7sn8ZBU) - fathomjournal.org

Organon & Co. Opens with 23.72% Gain, Surpassing S&P 500's 0.8% Rise - Markets Mojo

Sun Pharma shares jump 9% as $11.75‑billion Organon buy seals entry into biosimilars, deal expected to close in 2027 - MSN

Win-win deal! Sun Pharma jumps 8% in two days with Organon zooming 42% in five daysAll about acquisition - MSN

Organon & Co (OGN) News Flow - Moomoo

What does Sun Pharma gain from its $12-billion Organon bid? - MSN

Sun Pharma’s $11.75 Billion Organon Deal: Dilip Shanghvi’s Bold Move Taking India to the World - Open Magazine

Sun Pharma to acquire Organon in $11.75 billion all-cash deal - MSN

India's largest drugmaker Sun Pharma to buy US firm Organon in $11.75 billion deal; shares jump 7% - MSN

Organon stock surges 31% on sweetened $13 billion takeover offer from Sun Pharma - MSN

MSN Money - MSN

India’s Sun Pharma takes biosimilar leap with $11.75 billion all-cash Organon acquisition - MSN

Sun Pharma's $11.75-billion Organon deal: What it means for Indian pharma M&As - MSN

'Buy' Sun Pharma shares: Up to 34% upside? What experts say on India's biggest ever pharma deal Organon - MSN

BT explainer: Why Sun Pharma's $11.75-bn Organon deal is priced below past pharma acquisitions - MSN

Sun Pharma to acquire Organon in $11.75 billion deal; eyes global top 25 spot - MSN

Organon jumps 15% as Sun Pharma agrees $11.8bn buyout - MSN

OGN (OGN) Form 144: multiple RSU vestings and dividend-equivalent share listings - Stock Titan

Sun Pharma to buy Organon in $11.75B deal, expanding global reach - MSN

Organon & Co To Go Ex-Dividend On May 11th, 2026 With 0.02 USD Dividend Per Share - Moomoo

Organon & Co. (OGN) 10K Form and Latest SEC Filings 2026 - MarketBeat

India’s Sun Pharma plots $12 billion Organon buyout for global reach - MSN

Sun Pharmaceutical share: Brokerages turn bullish post Organon deal, peg up to 16% upside; check latest target prices - MSN

Key deals this week: Organon, ARC Resources, Nebius, Eli Lilly and more - MSN

Organon SVP, corporate controller Holzbaur sells $353,080 stock By Investing.com - Investing.com Australia

Organon SVP, corporate controller Holzbaur sells $353,080 stock - Investing.com

Organon (OGN) controller sells 26,448 shares, ends direct stake - Stock Titan

OGN SEC FilingsORGANON & CO 10-K, 10-Q, 8-K Forms - Stock Titan

Organon Insider Bought Shares Worth $353,080, According to a Recent SEC Filing - marketscreener.com

OGN | Organon & Co. FinancialsIncome Statement - Quiver Quantitative

Organon SVP Lynette Holzbaur acquires $353,080 in company stock By Investing.com - Investing.com South Africa

Organon SVP Lynette Holzbaur acquires $353,080 in company stock - Investing.com

Organon (OGN) controller boosts stake with 26,448-share purchase - Stock Titan

Organon & Co stock hits 52-week high at 13.4 USD - Investing.com Australia

Organon Buyout By Sun Pharma Shifts Focus To Cash Value And Timing - Yahoo Finance

Research Alert: CFRA Retains Hold Rating On Shares Of Organon & Co. Following Q1 Results - Moomoo

Organon & Co stock hits 52-week high at 13.4 USD By Investing.com - Investing.com South Africa

How big is Organon’s biosimilar push for Sun Pharma? - MSN

Sun Pharma Signs Definitive Agreement to Acquire Organon & Company in $11.75 Billion Deal - scanx.trade

Halper Sadeh LLC is Investigating Whether HLX, OGN, XOMA, RMAX are Obtaining Fair Deals for their Shareholders - GlobeNewswire Inc.

Son rise at Sun: Decoding the architecture of Dilip Shanghvi’s global empire - Mint

Sun Pharma explores funding mix for $12 billion Organon deal - ET Pharma

Organon shares rally 16% in premarket as Sun Pharma announces buyout - MSN

Sun Pharma to acquire Organon for $11.75bn - MSN

Bonds, Loans and a Bold Leap: Inside Sun Pharma's Plan to Finance $12-Bn Organon Deal - outlookbusiness.com

Finanzdaten der Organon Co-Aktie (OGN)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie OGN